Red blood cell alloimmunization in sickle cell disease and in thalassaemia: current status, future perspectives and potential role of molecular typing
Red blood cell (RBC) transfusions are a milestone in the treatment for sickle cell anaemia (SSA) and for thalassaemia. RBC alloimmunization remains a major challenge of chronic transfusion therapy, and it can lead to adverse life‐threatening events. The alloimmunization risk could depend on multiple...
Saved in:
| Published in | Vox sanguinis Vol. 106; no. 3; pp. 197 - 208 |
|---|---|
| Main Authors | , |
| Format | Journal Article |
| Language | English |
| Published |
England
Blackwell Publishing Ltd
01.04.2014
S. Karger AG |
| Subjects | |
| Online Access | Get full text |
| ISSN | 0042-9007 1423-0410 1423-0410 |
| DOI | 10.1111/vox.12086 |
Cover
| Abstract | Red blood cell (RBC) transfusions are a milestone in the treatment for sickle cell anaemia (SSA) and for thalassaemia. RBC alloimmunization remains a major challenge of chronic transfusion therapy, and it can lead to adverse life‐threatening events. The alloimmunization risk could depend on multiple factors such as the number of transfusions and, most of all, the genetic background. Different ethnic groups are predisposed to immunization because of a significant degree of RBC antigenic mismatch between donor and recipient. There is no universal agreement and standards for the most appropriate selection of RBC units in chronically transfused subjects. Current practice only deals with compatibility of ABO, Rh and K antigens. Molecular RBC antigenic matching extended to other blood group systems is an innovative strategy to ensure a better quality and effectiveness of transfusion therapy. |
|---|---|
| AbstractList | Red blood cell (RBC) transfusions are a milestone in the treatment for sickle cell anaemia (SSA) and for thalassaemia. RBC alloimmunization remains a major challenge of chronic transfusion therapy, and it can lead to adverse life-threatening events. The alloimmunization risk could depend on multiple factors such as the number of transfusions and, most of all, the genetic background. Different ethnic groups are predisposed to immunization because of a significant degree of RBC antigenic mismatch between donor and recipient. There is no universal agreement and standards for the most appropriate selection of RBC units in chronically transfused subjects. Current practice only deals with compatibility of ABO, Rh and K antigens. Molecular RBC antigenic matching extended to other blood group systems is an innovative strategy to ensure a better quality and effectiveness of transfusion therapy. Red blood cell ( RBC ) transfusions are a milestone in the treatment for sickle cell anaemia ( SSA ) and for thalassaemia. RBC alloimmunization remains a major challenge of chronic transfusion therapy, and it can lead to adverse life‐threatening events. The alloimmunization risk could depend on multiple factors such as the number of transfusions and, most of all, the genetic background. Different ethnic groups are predisposed to immunization because of a significant degree of RBC antigenic mismatch between donor and recipient. There is no universal agreement and standards for the most appropriate selection of RBC units in chronically transfused subjects. Current practice only deals with compatibility of ABO , Rh and K antigens. Molecular RBC antigenic matching extended to other blood group systems is an innovative strategy to ensure a better quality and effectiveness of transfusion therapy. Red blood cell (RBC) transfusions are a milestone in the treatment for sickle cell anaemia (SSA) and for thalassaemia. RBC alloimmunization remains a major challenge of chronic transfusion therapy, and it can lead to adverse life-threatening events. The alloimmunization risk could depend on multiple factors such as the number of transfusions and, most of all, the genetic background. Different ethnic groups are predisposed to immunization because of a significant degree of RBC antigenic mismatch between donor and recipient. There is no universal agreement and standards for the most appropriate selection of RBC units in chronically transfused subjects. Current practice only deals with compatibility of ABO, Rh and K antigens. Molecular RBC antigenic matching extended to other blood group systems is an innovative strategy to ensure a better quality and effectiveness of transfusion therapy.Red blood cell (RBC) transfusions are a milestone in the treatment for sickle cell anaemia (SSA) and for thalassaemia. RBC alloimmunization remains a major challenge of chronic transfusion therapy, and it can lead to adverse life-threatening events. The alloimmunization risk could depend on multiple factors such as the number of transfusions and, most of all, the genetic background. Different ethnic groups are predisposed to immunization because of a significant degree of RBC antigenic mismatch between donor and recipient. There is no universal agreement and standards for the most appropriate selection of RBC units in chronically transfused subjects. Current practice only deals with compatibility of ABO, Rh and K antigens. Molecular RBC antigenic matching extended to other blood group systems is an innovative strategy to ensure a better quality and effectiveness of transfusion therapy. Red blood cell (RBC) transfusions are a milestone in the treatment for sickle cell anaemia (SSA) and for thalassaemia. RBC alloimmunization remains a major challenge of chronic transfusion therapy, and it can lead to adverse life-threatening events. The alloimmunization risk could depend on multiple factors such as the number of transfusions and, most of all, the genetic background. Different ethnic groups are predisposed to immunization because of a significant degree of RBC antigenic mismatch between donor and recipient. There is no universal agreement and standards for the most appropriate selection of RBC units in chronically transfused subjects. Current practice only deals with compatibility of ABO, Rh and K antigens. Molecular RBC antigenic matching extended to other blood group systems is an innovative strategy to ensure a better quality and effectiveness of transfusion therapy. [PUBLICATION ABSTRACT] |
| Author | Pierelli, L. Matteocci, A. |
| Author_xml | – sequence: 1 givenname: A. surname: Matteocci fullname: Matteocci, A. organization: Immunohematology and Transfusion Medicine Unit, Transfusion Medicine Department, San Camillo Forlanini Hospital, Rome, Italy – sequence: 2 givenname: L. surname: Pierelli fullname: Pierelli, L. email: Luca Pierelli, Immunohematology and Transfusion Medicine Unit, Transfusion Medicine Department, San Camillo Forlanini Hospital, Circonvallazione Gianicolense 87, 00152 Rome, Italy, luca.pierelli@tiscali.it organization: Immunohematology and Transfusion Medicine Unit, Transfusion Medicine Department, San Camillo Forlanini Hospital, Rome, Italy |
| BackLink | https://www.ncbi.nlm.nih.gov/pubmed/24117723$$D View this record in MEDLINE/PubMed |
| BookMark | eNqNkc9u1DAQxi1URLeFAy-ALHEBRFo7ceJsb6gtW6QVRaj8uVleewJuHTvYTtvlQXhevLttD5Wo8GUO8_u-8Xyzg7acd4DQc0r2aH77l_56j5akbR6hCWVlVRBGyRaaEMLKYkoI30Y7MZ4TQtqyrZ-g7ZJRynlZTdCfz6DxwnqvsQJrsbTWm74fnfktk_EOG4ejURcWNn1tIsgIWDq9aqWf0soYJfRGHmA1hgAu4ZhkGuNb3I1pDIAHCHEAlcwlxLVw8CljRlocfDb2He5zVaOVAaflYNyPp-hxJ22EZzd1F315f3x2eFLMT2cfDt_NC8XqaVPUqtUlJaTroKm5Jp3qOKtZ02iuGsYkSCAArNO6mraK81otpK6rttWqqxctVLvozcZ3dINcXuXtxRBML8NSUCJW4YocrliHm-FXG3gI_tcIMYnexFUq0oEfo6A1bfJ4ysn_oCSbc8Iz-vIeeu7H4PLWmSLtlLKKrma_uKHGRQ_67pe3l8zA6w2ggo8xQPfgIvv3WGXS-twpSGMfUlwZC8t_W4uvp99vFcVGYWKC6zuFDBei4RWvxbePM_GpnZ_M6FEjzqq_5Eze1g |
| CODEN | VOSAAD |
| CitedBy_id | crossref_primary_10_1111_voxs_12416 crossref_primary_10_1111_vox_12762 crossref_primary_10_21307_immunohematology_2019_020 crossref_primary_10_55010_imcjms_18_004 crossref_primary_10_1097_MPH_0000000000001288 crossref_primary_10_36106_ijsr_1631525 crossref_primary_10_1016_j_transci_2020_102840 crossref_primary_10_1080_03630269_2019_1709205 crossref_primary_10_4103_ajts_ajts_107_21 crossref_primary_10_1016_j_tmrv_2016_06_001 crossref_primary_10_1111_trf_17244 crossref_primary_10_17945_kjbt_2017_28_3_282 crossref_primary_10_1111_voxs_12299 crossref_primary_10_17945_kjbt_2018_29_2_188 crossref_primary_10_1111_voxs_12410 crossref_primary_10_1186_s12864_024_10444_6 crossref_primary_10_1016_j_tracli_2019_03_002 crossref_primary_10_1021_acs_analchem_8b01078 crossref_primary_10_1016_j_tmrv_2014_08_003 crossref_primary_10_1016_j_tmrv_2016_05_011 crossref_primary_10_1016_j_transci_2020_103006 crossref_primary_10_1016_j_htct_2018_04_001 crossref_primary_10_1002_mgg3_1701 crossref_primary_10_3390_jcm8122124 crossref_primary_10_1016_j_transci_2019_102678 crossref_primary_10_1111_tme_12806 crossref_primary_10_1002_ajh_24211 crossref_primary_10_1517_21678707_2014_918503 crossref_primary_10_25259_JLP_2023_7_8__1848 crossref_primary_10_1111_tme_12732 crossref_primary_10_1007_s12288_020_01283_y crossref_primary_10_1080_03630269_2023_2269837 crossref_primary_10_1111_tme_12531 crossref_primary_10_1016_j_transci_2020_102909 crossref_primary_10_21307_immunohematology_2018_022 crossref_primary_10_1016_j_tracli_2023_02_001 crossref_primary_10_5858_arpa_2017_0251_RS crossref_primary_10_1016_j_transci_2014_12_006 crossref_primary_10_1159_000369179 crossref_primary_10_3389_fimmu_2017_00700 crossref_primary_10_1038_s41598_020_78333_y crossref_primary_10_1016_j_transci_2017_03_008 crossref_primary_10_1111_vox_13351 crossref_primary_10_3109_03630269_2014_982255 crossref_primary_10_1016_j_tracli_2019_06_004 crossref_primary_10_1016_j_transci_2018_05_018 crossref_primary_10_1111_tme_12643 crossref_primary_10_1016_j_htct_2017_08_001 crossref_primary_10_1111_trf_13065 crossref_primary_10_1111_trf_15002 crossref_primary_10_1007_s00277_020_04104_4 crossref_primary_10_1016_j_hoc_2016_01_006 crossref_primary_10_1182_bloodadvances_2020002695 crossref_primary_10_5348_ijbti_2015_15_OA_1 crossref_primary_10_1111_trf_14508 crossref_primary_10_1182_bloodadvances_2024012923 crossref_primary_10_1159_000504144 crossref_primary_10_1016_j_bjhh_2015_07_003 crossref_primary_10_1016_j_hoc_2019_05_005 crossref_primary_10_1111_vox_12432 crossref_primary_10_1111_voxs_12522 crossref_primary_10_21307_immunohematology_2019_075 crossref_primary_10_1111_trf_13259 crossref_primary_10_1016_j_transci_2017_01_003 crossref_primary_10_21307_immunohematology_2020_053 crossref_primary_10_4103_joah_joah_122_21 crossref_primary_10_1016_j_transci_2016_11_007 crossref_primary_10_1111_voxs_12321 crossref_primary_10_1111_voxs_12485 crossref_primary_10_1159_000489471 crossref_primary_10_4103_ijmr_IJMR_940_17 crossref_primary_10_1080_22201181_2016_1168611 crossref_primary_10_1111_vox_12515 crossref_primary_10_1111_voxs_12241 |
| Cites_doi | 10.1111/j.1423-0410.2010.01462.x 10.1097/MPH.0b013e3182208154 10.1097/MAJ.0b013e3181c70e14 10.1111/j.1537-2995.1961.tb00048.x 10.1016/j.tracli.2012.03.004 10.1182/blood-2009-06-227793 10.1111/j.1537-2995.2008.02014.x 10.1016/j.transci.2011.08.003 10.1046/j.1537-2995.1990.30690333485.x 10.1002/ajh.22167 10.1016/j.tracli.2010.09.002 10.1111/j.1537-2995.2009.02369.x 10.1016/j.transci.2010.12.014 10.1046/j.1365-2141.1999.01127.x 10.1111/j.0041-1132.2004.00658.x 10.1182/blood-2008-03-146415 10.1111/j.1537-2995.2009.02435.x 10.1046/j.1537-2995.1985.25285169198.x 10.1111/j.1537-2995.2008.01693.x 10.1111/j.1537-2995.2012.03819.x 10.1111/j.1537-2995.2006.00764.x 10.1182/blood-2008-11-146860 10.1111/j.1537-2995.2008.01980.x 10.1002/ajh.21442 10.1111/j.1365-2141.2005.05408.x 10.1016/j.tmrv.2007.12.002 10.1046/j.1537-2995.1994.34794330008.x 10.1111/j.1537-2995.2007.01468.x 10.21307/immunohematology-2019-169 10.21307/immunohematology-2019-297 10.1016/j.transci.2010.12.013 10.1111/j.1537-2995.2012.03570.x 10.1111/j.1537-2995.2010.03045.x 10.1111/j.1537-2995.2009.02518.x 10.1111/j.1365-2141.2008.07285.x 10.1182/blood.V96.10.3369 10.1111/j.1537-2995.2011.03234.x 10.1046/j.1537-2995.2003.00549.x 10.1111/j.1365-2141.2011.08576.x 10.3109/08880018.2011.568595 10.1182/blood-2011-11-327361 10.1111/j.1751-2824.2012.01572.x 10.1111/j.1537-2995.2009.02462.x 10.1046/j.1365-2141.2001.02819.x 10.1111/j.1537-2995.2012.03796.x 10.1111/j.1537-2995.2009.02456.x 10.1056/NEJM199006073222301 10.1111/j.1537-2995.2011.03502.x 10.1111/j.1537-2995.2009.02185.x 10.1016/j.transci.2011.07.014 10.1111/j.1537-2995.2007.01433.x 10.1111/j.1751-2824.2012.01594.x 10.1111/j.1423-0410.2011.01517.x 10.1182/blood.V76.7.1431.1431 10.1111/bjh.12061 10.1111/j.1751-2824.2012.01574.x 10.1111/j.1423-0410.1990.tb02055.x 10.1046/j.1537-2995.2002.00126.x 10.1159/000212062 10.1016/j.tracli.2011.09.001 10.1111/j.1423-0410.2009.01185.x 10.21307/immunohematology-2019-144 |
| ContentType | Journal Article |
| Copyright | 2013 International Society of Blood Transfusion 2013 International Society of Blood Transfusion. Copyright Vox Sanguinis © 2014 International Society of Blood Transfusion |
| Copyright_xml | – notice: 2013 International Society of Blood Transfusion – notice: 2013 International Society of Blood Transfusion. – notice: Copyright Vox Sanguinis © 2014 International Society of Blood Transfusion |
| DBID | BSCLL AAYXX CITATION CGR CUY CVF ECM EIF NPM 7QL 7T5 7TM 7U9 C1K H94 K9. M7N 7X8 7U1 ADTOC UNPAY |
| DOI | 10.1111/vox.12086 |
| DatabaseName | Istex CrossRef Medline MEDLINE MEDLINE (Ovid) MEDLINE MEDLINE PubMed Bacteriology Abstracts (Microbiology B) Immunology Abstracts Nucleic Acids Abstracts Virology and AIDS Abstracts Environmental Sciences and Pollution Management AIDS and Cancer Research Abstracts ProQuest Health & Medical Complete (Alumni) Algology Mycology and Protozoology Abstracts (Microbiology C) MEDLINE - Academic Risk Abstracts Unpaywall for CDI: Periodical Content Unpaywall |
| DatabaseTitle | CrossRef MEDLINE Medline Complete MEDLINE with Full Text PubMed MEDLINE (Ovid) Virology and AIDS Abstracts Bacteriology Abstracts (Microbiology B) Algology Mycology and Protozoology Abstracts (Microbiology C) Nucleic Acids Abstracts AIDS and Cancer Research Abstracts ProQuest Health & Medical Complete (Alumni) Immunology Abstracts Environmental Sciences and Pollution Management MEDLINE - Academic Risk Abstracts |
| DatabaseTitleList | Risk Abstracts CrossRef MEDLINE MEDLINE - Academic Virology and AIDS Abstracts |
| Database_xml | – sequence: 1 dbid: NPM name: PubMed url: https://proxy.k.utb.cz/login?url=http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed sourceTypes: Index Database – sequence: 2 dbid: EIF name: MEDLINE url: https://proxy.k.utb.cz/login?url=https://www.webofscience.com/wos/medline/basic-search sourceTypes: Index Database – sequence: 3 dbid: UNPAY name: Unpaywall url: https://proxy.k.utb.cz/login?url=https://unpaywall.org/ sourceTypes: Open Access Repository |
| DeliveryMethod | fulltext_linktorsrc |
| Discipline | Medicine |
| EISSN | 1423-0410 |
| EndPage | 208 |
| ExternalDocumentID | 10.1111/vox.12086 3251957221 24117723 10_1111_vox_12086 VOX12086 ark_67375_WNG_P8LHG1D6_T |
| Genre | reviewArticle Journal Article Review |
| GroupedDBID | --- .3N .55 .GA .GJ .Y3 05W 0R~ 0~B 10A 123 1OB 1OC 29R 30W 31~ 33P 36B 3SF 4.4 50Y 50Z 51W 51X 52M 52N 52O 52P 52R 52S 52T 52U 52V 52W 52X 53G 5HH 5LA 5RE 5VS 66C 702 7PT 8-0 8-1 8-3 8-4 8-5 8UI 8UM 930 A01 A03 AAESR AAEVG AAHQN AAIPD AAMMB AAMNL AANHP AANLZ AAONW AASGY AAXRX AAYCA AAYIC AAZKR ABBTS ABCQN ABCUV ABDBF ABEML ABJNI ABLJU ABPVW ABQWH ABWCG ABXGK ACAHQ ACBWZ ACCZN ACGFS ACGOF ACMXC ACPOU ACPRK ACQXL ACRPL ACSCC ACUHS ACXBN ACXQS ACYXJ ADBBV ADBTR ADEOM ADIZJ ADKYN ADMGS ADNMO ADOZA ADXAS ADZMN AEFGJ AEIGN AEIMD AENEX AEUYR AEYWJ AFBPY AFEBI AFFNX AFFPM AFGKR AFRAH AFSIO AFWVQ AFZJQ AGHNM AGQPQ AGXDD AGYGG AHBTC AHEFC AHMBA AIACR AIDQK AIDYY AIQQE AITYG AIURR ALAGY ALMA_UNASSIGNED_HOLDINGS ALUQN ALVPJ AMBMR AMYDB ASPBG ATUGU AVWKF AZBYB AZFZN AZVAB BAFTC BDRZF BFHJK BHBCM BMXJE BROTX BRXPI BSCLL BY8 C45 CAG COF CS3 CYUIP D-6 D-7 D-E D-F DCZOG DPXWK DR2 DRFUL DRMAN DRSTM DU5 E0A EAD EAP EBC EBD EBS EGARE EJD EMB EMK EMOBN ESX EX3 F00 F5P FB. FEDTE FUBAC FZ0 G-S G.N GODZA H.X HF~ HGLYW HVGLF HZI HZ~ IHE IX1 J0M J5H K48 KBYEO L7B LATKE LC2 LC3 LEEKS LH4 LITHE LOXES LP6 LP7 LUTES LW6 LYRES MEWTI MK4 MRFUL MRMAN MRSTM MSFUL MSMAN MSSTM MXFUL MXMAN MXSTM N04 N05 N9A NF~ O1H O66 O9- OIG OVD P2W P2X P2Z P4B P4D PALCI PQQKQ Q.N Q11 QB0 R.K RIWAO RJQFR RKO ROL RX1 SAMSI SUPJJ SV3 TEORI TUS UB1 UJ6 W8V W99 WBKPD WHWMO WIH WIJ WIK WOHZO WOW WQJ WVDHM WXI WXSBR X7M XG1 YFH ZGI ZXP ZZTAW ~IA ~WT AAHHS ACCFJ AEEZP AEQDE AEUQT AFPWT AIWBW AJBDE RIG WUP AAYXX CITATION CGR CUY CVF ECM EIF NPM 7QL 7T5 7TM 7U9 C1K H94 K9. M7N 7X8 7U1 ADTOC UNPAY |
| ID | FETCH-LOGICAL-c4596-5c8d2100ffe657d0fcf745466d7c644aeae0ee4fdd398c775cbad5388dcf5b8e3 |
| IEDL.DBID | DR2 |
| ISSN | 0042-9007 1423-0410 |
| IngestDate | Tue Aug 19 20:35:02 EDT 2025 Thu Jul 10 18:31:52 EDT 2025 Fri Jul 11 11:51:13 EDT 2025 Sat Jul 26 03:30:13 EDT 2025 Mon Jul 21 05:37:27 EDT 2025 Thu Apr 24 23:04:19 EDT 2025 Wed Oct 01 02:51:45 EDT 2025 Wed Jan 22 16:25:55 EST 2025 Sun Sep 21 06:17:28 EDT 2025 |
| IsDoiOpenAccess | true |
| IsOpenAccess | true |
| IsPeerReviewed | true |
| IsScholarly | true |
| Issue | 3 |
| Keywords | transfusion strategy blood groups RBC antigens and antibodies immunohaematology genotyping |
| Language | English |
| License | http://onlinelibrary.wiley.com/termsAndConditions#vor 2013 International Society of Blood Transfusion. |
| LinkModel | DirectLink |
| MergedId | FETCHMERGED-LOGICAL-c4596-5c8d2100ffe657d0fcf745466d7c644aeae0ee4fdd398c775cbad5388dcf5b8e3 |
| Notes | ark:/67375/WNG-P8LHG1D6-T istex:CC310AE6872AD0458956CE0935775BF4C41606EB ArticleID:VOX12086 ObjectType-Article-1 SourceType-Scholarly Journals-1 ObjectType-Feature-2 content type line 14 ObjectType-Review-3 content type line 23 ObjectType-Article-2 ObjectType-Feature-1 |
| OpenAccessLink | https://proxy.k.utb.cz/login?url=https://onlinelibrary.wiley.com/doi/pdfdirect/10.1111/vox.12086 |
| PMID | 24117723 |
| PQID | 1508914316 |
| PQPubID | 41227 |
| PageCount | 12 |
| ParticipantIDs | unpaywall_primary_10_1111_vox_12086 proquest_miscellaneous_1516745170 proquest_miscellaneous_1510111707 proquest_journals_1508914316 pubmed_primary_24117723 crossref_primary_10_1111_vox_12086 crossref_citationtrail_10_1111_vox_12086 wiley_primary_10_1111_vox_12086_VOX12086 istex_primary_ark_67375_WNG_P8LHG1D6_T |
| ProviderPackageCode | CITATION AAYXX |
| PublicationCentury | 2000 |
| PublicationDate | April 2014 |
| PublicationDateYYYYMMDD | 2014-04-01 |
| PublicationDate_xml | – month: 04 year: 2014 text: April 2014 |
| PublicationDecade | 2010 |
| PublicationPlace | England |
| PublicationPlace_xml | – name: England – name: Amsterdam |
| PublicationTitle | Vox sanguinis |
| PublicationTitleAlternate | Vox Sang |
| PublicationYear | 2014 |
| Publisher | Blackwell Publishing Ltd S. Karger AG |
| Publisher_xml | – name: Blackwell Publishing Ltd – name: S. Karger AG |
| References | Batina-Agasa S, Dupont E, Kayembe T, et al.: Multiple transfusions for sickle cell disease in the Democratic of Congo: the importance of the hepatitis C virus. Transfus Clin Biol 2010; 17:254-259 Rosse WF, Gallagher D, Kinney TR, et al.: Transfusion and alloimmunization in sickle cell disease. The Cooperative Study of Sickle Cell Disease. Blood 1990; 76:1431-1437 Campbell-Lee S: Red blood cell alloimmunization in sickle cell anemia: more questions than answers? Transfusion 2012; 52:214-216 Bauer MP, Wiersun-Osselton J, Schipperus M, et al.: Clinical predictors of alloimmunization after red blood cell transfusion. Transfusion 2007; 47:2066-2071 Schonewille H, Brand A: Alloimmunization to red blood cell antigens after universal leucodepletion. A regional multicentre retrospective study. Br J Haematol 2005; 129:151-156 Higgins JM, Sloan RS: Stochastic modeling of human RBC alloimmunization: evidence for a distinct population of immunologic responders. Blood 2008; 112:2546-2553 El Danasoury AS, Eissa DG, Abdo RM, et al.: Red blood cell alloimmunization in transfusion-dependent Egyptian patients with thalassemia in a limited donor exposure program. Transfusion 2012; 52:43-47 Olujohungbe A, Hambleton I, Stephens L, et al.: Red cell antibodies in patients with homozygous sickle cell disease: a comparison of patients in Jamaica and the United Kingdom. Br J Haematol 2001; 113:661-665 AABB. Standards for Blood Banks and Transfusion Services, 27th edn. Bethesda, USA, AABB, 2011 Scheunemann LP, Ataga KI: Delayed hemolytic transfusion reaction in sickle cell disease. Am J Med Sci 2010; 339:266-269 Avent ND: Large-scale blood group genotyping-clinical implications. Br J Haematol 2008; 144:3-13 LaSalle-Williams M, Nuss R, Le T, et al.: Extended red blood cell antigen matching for transfusion in sickle cell disease: a review of a 14 years experience from a single center. Transfusion 2011; 51:1732-1739 Ameen R, Al-Shemmari S, Al-Humood S, et al.: RBC alloimmunization and autoimmunization among transfusion-dependent Arab thalassemia patients. Transfusion 2003; 43:1604-1610 Cheng CK, Lee CK, Lin CK: Clinically significant red blood cell antibodies in chronically transfused patients: a survey of Chinese thalassemia major patients and literature review. Transfusion 2012; 52:2220-2224 Storry JR, Castilho L, Daniels G, et al.: International Society of Blood Transfusion Working Party on red cell immunogenetics and blood group terminology: Berlin report. Vox Sang 2011; 101:77-82 Garratty G: What is a clinically significant antibody? ISBT Sci Ser 2012; 7:54-57 Ameen R, Al Shemmari S, Al-Bashir A: Red blood cell alloimmunization among sickle cell Kuwaiti Arab patients who received red blood cell transfusion. Transfusion 2009; 49:1649-1654 Flegel WA: Molecular genetics and clinical applications for RH. Transfus Apher Sci 2011; 44:81-91 Vickinsky EP: The prevention and management of alloimmunization in sickle cell disease: The benefit of extended phenotypic matching of red blood cells. Immunohematology 2012; 28:20-23 Tormey CA, Stack G: The persistence and evanescence of blood group alloantibodies in men. Transfusion 2009; 49:505-512 Picard C, Frassati C, Basire A, et al.: Positive association of DRB1*04 and DRB1*15 alleles with Fya immunization in a Southern European population. Transfusion 2009; 49:2412-2417 Noizat-Pirenne F: Relevance of alloimmunization in haemolytic transfusion reaction in sickle cell disease. Transfus Clin Biol 2012; 19:132-138 Bao W, Zhong H, Li X, et al.: Immune regulation in chronically transfused allo-antibody responder and nonresponder patients with sickle cell disease and β-thalassemia major. Am J Hematol 2011; 86:1001-1006 Zimring JC, Spitalnik SL, Roback JD, et al.: Transfusion-induced autoantibodies and differential immunogenicity of blood group antigens: a novel hypothesis. Transfusion 2007; 47:2189-2196 Schonewille H, De Vries RRP, Brand A: Alloimmune response after additional red blood cell antigen challenge in immunized haematooncology patients. Transfusion 2009; 49:453-457 Azarkeivan A, Ansari S, Ahmadi MH, et al.: Blood transfusion and alloimmunization in patients with thalassemia: multicenter study. Pediatr Hematol Oncol 2011; 28:479-485 Garratty G: Autoantibodies induced by blood transfusion. Transfusion 2004; 44:5-9 Yazdanbakhsh Y, Ware RE, Noizet-Pirenne F: Red blood cell alloimmunization in sickle cell disease: pathophysiology, risk factors, and transfusion management. Blood 2012; 120:528-537 Giblett ER: A critique of the theoretical hazard of inter vs. intra-racial transfusion. Transfusion 1961; 1:233-238 Poole J: What methods and process flow can assist in alloantibody identification? ISBT Sci Ser 2012; 7:58-61 Tormey CA, Stack G: Immunogenicity of blood group antigens: a mathematical model corrected for antibody evanescence with exclusion of naturally occurring and pregnancy related antibodies. Blood 2009; 114:4279-4282 Reid ME: Application and experience with PCR-based assays to predict blood group antigens. Transfus Med Hemother 2009; 36:168-178 Guirat-Dhouib N, Mezri M, Hmida H, et al.: High frequency of autoimmunization among transfusion-dependent Tunisian thalassemia patients. Transfus Apher Sci 2011; 45:199-202 Reid ME, Lomas-Francis C: The Blood Group Antigen Facts Book, 3rd edn. San Diego, CA, USA, Elsevier Academic Press, 2012 Win N, New H, Lee E, et al.: Hyperhemolysis syndrome in sickle cell disease: case report (recurrent episode) and literature review. Transfusion 2008; 48:1231-1238 Morelati F, Arnaboldi P, Barocci F, et al.: Strategies for the transfusion of subjects with complex red cell immunization: the Bank of rare blood donors of the Region of Lombardy. Blood Transfus 2007; 5:217-226 Saied DA, Kaddah AM, Badr Eldin RM, et al.: Alloimmunization and erythrocyte autoimmunization in transfusion-dependent Egyptian thalassemic patients. J Ped Hematol Oncol 2011; 33:409-414 Shander A, Hofmann A, Ozawa S, et al.: Activity-based costs of blood transfusions in surgical patients at four hospitals. Transfusion 2010; 50:753-765 Miller ST, Kim HY, Weiner DL, et al.: Red blood cell alloimmunization in sickle cell disease: prevalence in 2010. Transfusion 2013; 54:704-709. Natakunda B: Red blood alloimmunization and antigen matching in sickle cell disease - the African perspective. ISBT Sci Ser 2012; 7:129-133 Chou ST, Westhoff CM: The role of molecular immunohematology in sickle cell disease. Transfus Apher Sci 2011; 44:73-79 Fluit CR, Kunst VA, Drenthe-Schonk AM: Incidence of red cell antibodies after multiple blood transfusions. Transfusion 1990; 30:532-535 Ribeiro KR, Guarnieri MH, da Costa DC, et al.: DNA array analysis for red cell antigens facilitates the transfusion support with antigen-matched blood in patients with sickle cell disease. Vox Sang 2009; 97:147-152 Badjie KSW, Tauscher C, Van Buskirk C, et al.: Red blood cell phenotype matching for various ethnic groups. Immunohematology 2011; 27:12-18 Hoppe C, Klitz W, Vichinsky E, et al.: HLA type and risk of alloimmunization in sickle cell disease. Am J Hematol 2009; 84:462-464 Klapper E, Zhang Y, Figueroa P, et al.: Toward extended phenotype matching: a new operational paradigm for the transfusion service. Transfusion 2010; 50:246-256 Spanos T, Karageorga M, Ladis V, et al.: Red cell alloantibodies in patients with thalassemia. Vox Sang 1990; 58:50-55 Sanz C, Nomdedeu M, Belkaid M, et al.: Red blood cell alloimmunization in transfused patients with myelodysplastic syndrome or chronic myelomonocytic leukemia. Transfusion 2013; 53:710-715. Thompson AA, Cunningham MJ, Singer ST, et al.: Red cell alloimmunization in a diverse population of transfused patients with thalassemia. Br J Haematol 2011; 153:121-128 Revelli N, Villa MA, Paccapelo C, et al.: The Immunohematology Reference Laboratory: the experience of the Policlinico Maggiore Hospital, Mangiagalli and Regina Elena Foundation, Milan. Blood Transfus 2009; 7:94-99 Zalpuri S, Zwaginga JJ, le Cessie S: Red blood cell alloimmunization and number of red blood cell transfusions. Vox Sang 2012; 102:144-149 Westhoff CM: The potential of blood group genotyping for transfusion medicine practice. Immunohematology 2008; 24:190-195 Noizat-Pirenne F, Tournamille C: Relevance of RH variants in transfusion of sickle cell patients. Transfus Clin Biol 2011; 18:527-535 Gupta R, Singh DK, Singh B, et al.: Alloimmunization to red cells in thalassemics: emerging problem and future strategies. Transfus Apher Sci 2011; 45:167-170 Castellino SM, Combs MR, Zimmerman SA, et al.: Erythrocyte autoantibodies in paediatric patients with sickle cell disease receiving transfusion therapy: frequency, characteristics and significance. Br J Haematol 1999; 104:189-194 Chou ST, Liem RI, Thompson AA: Challenges of alloimmunization in patients with haemoglobinopathies. Br J Haematol 2012; 159:394-404 Natukanda B, Schonewille H, Ndugwa C, et al.: Red blood cell alloimmunization in sickle cell disease in Uganda. Transfusion 2010; 50:20-25 Noor Haslina MN, Arrifin N, Illuni Hayati I, et al.: Red cell immunization in multiply transfused Malay thalassemic patients. Southest Asian J Trop Med Public Health 2006; 37:1015-1020 Anstee DJ: Red cell genotyping and the future of pretransfusion testing. Blood 2009; 114:248-256 Vichinsky EP, Earles A, Johnson RA, et al.: Alloimmunization in sickle cell anemia and transfusion of racially unmatched blood. N Engl J Med 1990; 322:1617-1621 Sirchia G, Zanella A, Parravicini A, et al.: Red cell alloantibodies in thalassemia major. Results of an Italian cooperative study. Transfusion 1985; 25:110-112 Singer ST, Wu V, Mignacca R, et al.: Alloimmunization and erythrocyte autoimmunization in transfusion-dependent thalassemia patients of predominantly Asian descent. Blood 2000; 96:3369-3373 Hillyer CD, Shaz BH, Winkler AM, et al.: Integrating molecular technologies for red blood cell typing and compatibility testing into blood centers and transfusion services. Transfus Med Rev 2008; 22:117-132 Castro O, Sandler SG, Houston-Yu P, et al.: Predicting the eff 2012; 120 2009; 84 1990; 58 2010; 17 2006; 37 2012; 19 2008; 144 2011; 18 2009; 114 2009; 49 2012; 52 1985; 25 2011; 153 2009; 97 2013; 54 2002; 42 1961; 1 2013; 53 2000; 96 1994; 34 2008; 24 2012; 28 2008; 22 2007; 5 2008; 112 2011; 28 2011; 27 2003; 43 2004; 44 1990; 30 1990; 76 2012; 102 2012 2011 2011; 33 1990; 322 1999; 104 2009; 36 2001; 113 2006; 46 2010; 339 2011; 51 2011; 86 2005; 129 2008; 48 2011; 44 2009; 7 2011; 45 2012; 159 2012; 7 2011; 101 2007; 47 2010; 50 e_1_2_10_23_1 e_1_2_10_46_1 e_1_2_10_69_1 e_1_2_10_44_1 e_1_2_10_42_1 Noor Haslina MN (e_1_2_10_58_1) 2006; 37 e_1_2_10_40_1 Revelli N (e_1_2_10_21_1) 2009; 7 e_1_2_10_70_1 e_1_2_10_2_1 e_1_2_10_72_1 e_1_2_10_4_1 Morelati F (e_1_2_10_16_1) 2007; 5 e_1_2_10_53_1 e_1_2_10_6_1 e_1_2_10_39_1 e_1_2_10_55_1 e_1_2_10_8_1 e_1_2_10_14_1 e_1_2_10_37_1 e_1_2_10_57_1 e_1_2_10_34_1 e_1_2_10_11_1 e_1_2_10_32_1 e_1_2_10_30_1 e_1_2_10_51_1 Reid ME (e_1_2_10_13_1) 2012 e_1_2_10_61_1 e_1_2_10_29_1 e_1_2_10_63_1 e_1_2_10_27_1 e_1_2_10_65_1 e_1_2_10_25_1 e_1_2_10_48_1 e_1_2_10_67_1 e_1_2_10_24_1 e_1_2_10_45_1 e_1_2_10_22_1 e_1_2_10_43_1 e_1_2_10_20_1 e_1_2_10_41_1 e_1_2_10_71_1 e_1_2_10_52_1 e_1_2_10_3_1 e_1_2_10_19_1 e_1_2_10_54_1 e_1_2_10_5_1 e_1_2_10_17_1 e_1_2_10_38_1 e_1_2_10_56_1 Klapper E (e_1_2_10_68_1) 2010; 50 e_1_2_10_7_1 e_1_2_10_15_1 e_1_2_10_36_1 e_1_2_10_35_1 e_1_2_10_9_1 e_1_2_10_59_1 e_1_2_10_10_1 e_1_2_10_33_1 e_1_2_10_31_1 e_1_2_10_50_1 AABB (e_1_2_10_18_1) 2011 e_1_2_10_60_1 Vickinsky EP (e_1_2_10_12_1) 2012; 28 e_1_2_10_62_1 e_1_2_10_64_1 e_1_2_10_28_1 e_1_2_10_49_1 e_1_2_10_66_1 e_1_2_10_26_1 e_1_2_10_47_1 |
| References_xml | – reference: Schonewille H, De Vries RRP, Brand A: Alloimmune response after additional red blood cell antigen challenge in immunized haematooncology patients. Transfusion 2009; 49:453-457 – reference: Rosse WF, Gallagher D, Kinney TR, et al.: Transfusion and alloimmunization in sickle cell disease. The Cooperative Study of Sickle Cell Disease. Blood 1990; 76:1431-1437 – reference: Olujohungbe A, Hambleton I, Stephens L, et al.: Red cell antibodies in patients with homozygous sickle cell disease: a comparison of patients in Jamaica and the United Kingdom. Br J Haematol 2001; 113:661-665 – reference: Natukanda B, Schonewille H, Ndugwa C, et al.: Red blood cell alloimmunization in sickle cell disease in Uganda. Transfusion 2010; 50:20-25 – reference: Chou ST, Westhoff CM: The role of molecular immunohematology in sickle cell disease. Transfus Apher Sci 2011; 44:73-79 – reference: Ameen R, Al Shemmari S, Al-Bashir A: Red blood cell alloimmunization among sickle cell Kuwaiti Arab patients who received red blood cell transfusion. Transfusion 2009; 49:1649-1654 – reference: Storry JR, Castilho L, Daniels G, et al.: International Society of Blood Transfusion Working Party on red cell immunogenetics and blood group terminology: Berlin report. Vox Sang 2011; 101:77-82 – reference: Noor Haslina MN, Arrifin N, Illuni Hayati I, et al.: Red cell immunization in multiply transfused Malay thalassemic patients. Southest Asian J Trop Med Public Health 2006; 37:1015-1020 – reference: Zalpuri S, Zwaginga JJ, le Cessie S: Red blood cell alloimmunization and number of red blood cell transfusions. Vox Sang 2012; 102:144-149 – reference: Schonewille H, van de Watering LMG, Brand A: Additional red blood cell alloantibodies after blood transfusion in a non hematologic alloimmunized patient cohort: is it time to take precautionary measures? Transfusion 2006; 46:630-635 – reference: Guirat-Dhouib N, Mezri M, Hmida H, et al.: High frequency of autoimmunization among transfusion-dependent Tunisian thalassemia patients. Transfus Apher Sci 2011; 45:199-202 – reference: Schonewille H, Brand A: Alloimmunization to red blood cell antigens after universal leucodepletion. A regional multicentre retrospective study. Br J Haematol 2005; 129:151-156 – reference: Badjie KSW, Tauscher C, Van Buskirk C, et al.: Red blood cell phenotype matching for various ethnic groups. Immunohematology 2011; 27:12-18 – reference: Picard C, Frassati C, Basire A, et al.: Positive association of DRB1*04 and DRB1*15 alleles with Fya immunization in a Southern European population. Transfusion 2009; 49:2412-2417 – reference: Higgins JM, Sloan RS: Stochastic modeling of human RBC alloimmunization: evidence for a distinct population of immunologic responders. Blood 2008; 112:2546-2553 – reference: Noizat-Pirenne F, Tournamille C: Relevance of RH variants in transfusion of sickle cell patients. Transfus Clin Biol 2011; 18:527-535 – reference: Shander A, Hofmann A, Ozawa S, et al.: Activity-based costs of blood transfusions in surgical patients at four hospitals. Transfusion 2010; 50:753-765 – reference: Morelati F, Arnaboldi P, Barocci F, et al.: Strategies for the transfusion of subjects with complex red cell immunization: the Bank of rare blood donors of the Region of Lombardy. Blood Transfus 2007; 5:217-226 – reference: Tahhan HR, Holbrook CT, Braddy LR, et al.: Antigen-matched donor blood in the transfusion management of patients with sickle cell disease. Transfusion 1994; 34:562-569 – reference: Vickinsky EP: The prevention and management of alloimmunization in sickle cell disease: The benefit of extended phenotypic matching of red blood cells. Immunohematology 2012; 28:20-23 – reference: Campbell-Lee S: Red blood cell alloimmunization in sickle cell anemia: more questions than answers? Transfusion 2012; 52:214-216 – reference: Giblett ER: A critique of the theoretical hazard of inter vs. intra-racial transfusion. Transfusion 1961; 1:233-238 – reference: Castellino SM, Combs MR, Zimmerman SA, et al.: Erythrocyte autoantibodies in paediatric patients with sickle cell disease receiving transfusion therapy: frequency, characteristics and significance. Br J Haematol 1999; 104:189-194 – reference: Hoppe C, Klitz W, Vichinsky E, et al.: HLA type and risk of alloimmunization in sickle cell disease. Am J Hematol 2009; 84:462-464 – reference: Tormey CA, Stack G: The persistence and evanescence of blood group alloantibodies in men. Transfusion 2009; 49:505-512 – reference: Cheng CK, Lee CK, Lin CK: Clinically significant red blood cell antibodies in chronically transfused patients: a survey of Chinese thalassemia major patients and literature review. Transfusion 2012; 52:2220-2224 – reference: Zimring JC, Spitalnik SL, Roback JD, et al.: Transfusion-induced autoantibodies and differential immunogenicity of blood group antigens: a novel hypothesis. Transfusion 2007; 47:2189-2196 – reference: Sanz C, Nomdedeu M, Belkaid M, et al.: Red blood cell alloimmunization in transfused patients with myelodysplastic syndrome or chronic myelomonocytic leukemia. Transfusion 2013; 53:710-715. – reference: Tormey CA, Stack G: Immunogenicity of blood group antigens: a mathematical model corrected for antibody evanescence with exclusion of naturally occurring and pregnancy related antibodies. Blood 2009; 114:4279-4282 – reference: Klapper E, Zhang Y, Figueroa P, et al.: Toward extended phenotype matching: a new operational paradigm for the transfusion service. Transfusion 2010; 50:246-256 – reference: Westhoff CM: The potential of blood group genotyping for transfusion medicine practice. Immunohematology 2008; 24:190-195 – reference: Spanos T, Karageorga M, Ladis V, et al.: Red cell alloantibodies in patients with thalassemia. Vox Sang 1990; 58:50-55 – reference: Reid ME, Lomas-Francis C: The Blood Group Antigen Facts Book, 3rd edn. San Diego, CA, USA, Elsevier Academic Press, 2012 – reference: Win N, New H, Lee E, et al.: Hyperhemolysis syndrome in sickle cell disease: case report (recurrent episode) and literature review. Transfusion 2008; 48:1231-1238 – reference: Ribeiro KR, Guarnieri MH, da Costa DC, et al.: DNA array analysis for red cell antigens facilitates the transfusion support with antigen-matched blood in patients with sickle cell disease. Vox Sang 2009; 97:147-152 – reference: Reid ME: Application and experience with PCR-based assays to predict blood group antigens. Transfus Med Hemother 2009; 36:168-178 – reference: LaSalle-Williams M, Nuss R, Le T, et al.: Extended red blood cell antigen matching for transfusion in sickle cell disease: a review of a 14 years experience from a single center. Transfusion 2011; 51:1732-1739 – reference: Garratty G: Autoantibodies induced by blood transfusion. Transfusion 2004; 44:5-9 – reference: Flegel WA: Molecular genetics and clinical applications for RH. Transfus Apher Sci 2011; 44:81-91 – reference: Yazdanbakhsh Y, Ware RE, Noizet-Pirenne F: Red blood cell alloimmunization in sickle cell disease: pathophysiology, risk factors, and transfusion management. Blood 2012; 120:528-537 – reference: Azarkeivan A, Ansari S, Ahmadi MH, et al.: Blood transfusion and alloimmunization in patients with thalassemia: multicenter study. Pediatr Hematol Oncol 2011; 28:479-485 – reference: Hillyer CD, Shaz BH, Winkler AM, et al.: Integrating molecular technologies for red blood cell typing and compatibility testing into blood centers and transfusion services. Transfus Med Rev 2008; 22:117-132 – reference: Scheunemann LP, Ataga KI: Delayed hemolytic transfusion reaction in sickle cell disease. Am J Med Sci 2010; 339:266-269 – reference: El Danasoury AS, Eissa DG, Abdo RM, et al.: Red blood cell alloimmunization in transfusion-dependent Egyptian patients with thalassemia in a limited donor exposure program. Transfusion 2012; 52:43-47 – reference: Anstee DJ: Red cell genotyping and the future of pretransfusion testing. Blood 2009; 114:248-256 – reference: Revelli N, Villa MA, Paccapelo C, et al.: The Immunohematology Reference Laboratory: the experience of the Policlinico Maggiore Hospital, Mangiagalli and Regina Elena Foundation, Milan. Blood Transfus 2009; 7:94-99 – reference: Thompson AA, Cunningham MJ, Singer ST, et al.: Red cell alloimmunization in a diverse population of transfused patients with thalassemia. Br J Haematol 2011; 153:121-128 – reference: Bauer MP, Wiersun-Osselton J, Schipperus M, et al.: Clinical predictors of alloimmunization after red blood cell transfusion. Transfusion 2007; 47:2066-2071 – reference: Avent ND: Large-scale blood group genotyping-clinical implications. Br J Haematol 2008; 144:3-13 – reference: Saied DA, Kaddah AM, Badr Eldin RM, et al.: Alloimmunization and erythrocyte autoimmunization in transfusion-dependent Egyptian thalassemic patients. J Ped Hematol Oncol 2011; 33:409-414 – reference: Garratty G: What is a clinically significant antibody? ISBT Sci Ser 2012; 7:54-57 – reference: Miller ST, Kim HY, Weiner DL, et al.: Red blood cell alloimmunization in sickle cell disease: prevalence in 2010. Transfusion 2013; 54:704-709. – reference: Chou ST, Liem RI, Thompson AA: Challenges of alloimmunization in patients with haemoglobinopathies. Br J Haematol 2012; 159:394-404 – reference: Vichinsky EP, Earles A, Johnson RA, et al.: Alloimmunization in sickle cell anemia and transfusion of racially unmatched blood. N Engl J Med 1990; 322:1617-1621 – reference: AABB. Standards for Blood Banks and Transfusion Services, 27th edn. Bethesda, USA, AABB, 2011 – reference: Gupta R, Singh DK, Singh B, et al.: Alloimmunization to red cells in thalassemics: emerging problem and future strategies. Transfus Apher Sci 2011; 45:167-170 – reference: Daniels G, Reid ME: Blood groups: the past 50 years. Transfusion 2010; 50:281-289 – reference: Poole J: What methods and process flow can assist in alloantibody identification? ISBT Sci Ser 2012; 7:58-61 – reference: Singer ST, Wu V, Mignacca R, et al.: Alloimmunization and erythrocyte autoimmunization in transfusion-dependent thalassemia patients of predominantly Asian descent. Blood 2000; 96:3369-3373 – reference: Natakunda B: Red blood alloimmunization and antigen matching in sickle cell disease - the African perspective. ISBT Sci Ser 2012; 7:129-133 – reference: Bao W, Zhong H, Li X, et al.: Immune regulation in chronically transfused allo-antibody responder and nonresponder patients with sickle cell disease and β-thalassemia major. Am J Hematol 2011; 86:1001-1006 – reference: Castro O, Sandler SG, Houston-Yu P, et al.: Predicting the effect of transfusing only phenotype-matched RBCs to patients with sickle cell disease: theoretical and practical implications. Transfusion 2002; 42:684-690 – reference: Ameen R, Al-Shemmari S, Al-Humood S, et al.: RBC alloimmunization and autoimmunization among transfusion-dependent Arab thalassemia patients. Transfusion 2003; 43:1604-1610 – reference: Sirchia G, Zanella A, Parravicini A, et al.: Red cell alloantibodies in thalassemia major. Results of an Italian cooperative study. Transfusion 1985; 25:110-112 – reference: Batina-Agasa S, Dupont E, Kayembe T, et al.: Multiple transfusions for sickle cell disease in the Democratic of Congo: the importance of the hepatitis C virus. Transfus Clin Biol 2010; 17:254-259 – reference: Fluit CR, Kunst VA, Drenthe-Schonk AM: Incidence of red cell antibodies after multiple blood transfusions. Transfusion 1990; 30:532-535 – reference: Noizat-Pirenne F: Relevance of alloimmunization in haemolytic transfusion reaction in sickle cell disease. Transfus Clin Biol 2012; 19:132-138 – year: 2011 – volume: 104 start-page: 189 year: 1999 end-page: 194 article-title: Erythrocyte autoantibodies in paediatric patients with sickle cell disease receiving transfusion therapy: frequency, characteristics and significance publication-title: Br J Haematol – volume: 1 start-page: 233 year: 1961 end-page: 238 article-title: A critique of the theoretical hazard of inter vs. intra‐racial transfusion publication-title: Transfusion – volume: 28 start-page: 479 year: 2011 end-page: 485 article-title: Blood transfusion and alloimmunization in patients with thalassemia: multicenter study publication-title: Pediatr Hematol Oncol – volume: 86 start-page: 1001 year: 2011 end-page: 1006 article-title: Immune regulation in chronically transfused allo‐antibody responder and nonresponder patients with sickle cell disease and β‐thalassemia major publication-title: Am J Hematol – volume: 49 start-page: 1649 year: 2009 end-page: 1654 article-title: Red blood cell alloimmunization among sickle cell Kuwaiti Arab patients who received red blood cell transfusion publication-title: Transfusion – volume: 50 start-page: 281 year: 2010 end-page: 289 article-title: Blood groups: the past 50 years publication-title: Transfusion – volume: 28 start-page: 20 year: 2012 end-page: 23 article-title: The prevention and management of alloimmunization in sickle cell disease: The benefit of extended phenotypic matching of red blood cells publication-title: Immunohematology – volume: 129 start-page: 151 year: 2005 end-page: 156 article-title: Alloimmunization to red blood cell antigens after universal leucodepletion. A regional multicentre retrospective study publication-title: Br J Haematol – volume: 42 start-page: 684 year: 2002 end-page: 690 article-title: Predicting the effect of transfusing only phenotype‐matched RBCs to patients with sickle cell disease: theoretical and practical implications publication-title: Transfusion – volume: 51 start-page: 1732 year: 2011 end-page: 1739 article-title: Extended red blood cell antigen matching for transfusion in sickle cell disease: a review of a 14 years experience from a single center publication-title: Transfusion – volume: 339 start-page: 266 year: 2010 end-page: 269 article-title: Delayed hemolytic transfusion reaction in sickle cell disease publication-title: Am J Med Sci – volume: 101 start-page: 77 year: 2011 end-page: 82 article-title: International Society of Blood Transfusion Working Party on red cell immunogenetics and blood group terminology: Berlin report publication-title: Vox Sang – volume: 47 start-page: 2066 year: 2007 end-page: 2071 article-title: Clinical predictors of alloimmunization after red blood cell transfusion publication-title: Transfusion – volume: 144 start-page: 3 year: 2008 end-page: 13 article-title: Large‐scale blood group genotyping‐clinical implications publication-title: Br J Haematol – volume: 46 start-page: 630 year: 2006 end-page: 635 article-title: Additional red blood cell alloantibodies after blood transfusion in a non hematologic alloimmunized patient cohort: is it time to take precautionary measures? publication-title: Transfusion – volume: 27 start-page: 12 year: 2011 end-page: 18 article-title: Red blood cell phenotype matching for various ethnic groups publication-title: Immunohematology – volume: 52 start-page: 214 year: 2012 end-page: 216 article-title: Red blood cell alloimmunization in sickle cell anemia: more questions than answers? publication-title: Transfusion – volume: 54 start-page: 704 year: 2013 end-page: 709 article-title: Red blood cell alloimmunization in sickle cell disease: prevalence in 2010 publication-title: Transfusion – volume: 36 start-page: 168 year: 2009 end-page: 178 article-title: Application and experience with PCR‐based assays to predict blood group antigens publication-title: Transfus Med Hemother – volume: 19 start-page: 132 year: 2012 end-page: 138 article-title: Relevance of alloimmunization in haemolytic transfusion reaction in sickle cell disease publication-title: Transfus Clin Biol – volume: 48 start-page: 1231 year: 2008 end-page: 1238 article-title: Hyperhemolysis syndrome in sickle cell disease: case report (recurrent episode) and literature review publication-title: Transfusion – volume: 37 start-page: 1015 year: 2006 end-page: 1020 article-title: Red cell immunization in multiply transfused Malay thalassemic patients publication-title: Southest Asian J Trop Med Public Health – volume: 58 start-page: 50 year: 1990 end-page: 55 article-title: Red cell alloantibodies in patients with thalassemia publication-title: Vox Sang – volume: 43 start-page: 1604 year: 2003 end-page: 1610 article-title: RBC alloimmunization and autoimmunization among transfusion‐dependent Arab thalassemia patients publication-title: Transfusion – volume: 50 start-page: 753 year: 2010 end-page: 765 article-title: Activity‐based costs of blood transfusions in surgical patients at four hospitals publication-title: Transfusion – volume: 159 start-page: 394 year: 2012 end-page: 404 article-title: Challenges of alloimmunization in patients with haemoglobinopathies publication-title: Br J Haematol – volume: 113 start-page: 661 year: 2001 end-page: 665 article-title: Red cell antibodies in patients with homozygous sickle cell disease: a comparison of patients in Jamaica and the United Kingdom publication-title: Br J Haematol – volume: 102 start-page: 144 year: 2012 end-page: 149 article-title: Red blood cell alloimmunization and number of red blood cell transfusions publication-title: Vox Sang – volume: 49 start-page: 505 year: 2009 end-page: 512 article-title: The persistence and evanescence of blood group alloantibodies in men publication-title: Transfusion – volume: 97 start-page: 147 year: 2009 end-page: 152 article-title: DNA array analysis for red cell antigens facilitates the transfusion support with antigen‐matched blood in patients with sickle cell disease publication-title: Vox Sang – volume: 7 start-page: 54 year: 2012 end-page: 57 article-title: What is a clinically significant antibody? publication-title: ISBT Sci Ser – volume: 34 start-page: 562 year: 1994 end-page: 569 article-title: Antigen‐matched donor blood in the transfusion management of patients with sickle cell disease publication-title: Transfusion – volume: 7 start-page: 58 year: 2012 end-page: 61 article-title: What methods and process flow can assist in alloantibody identification? publication-title: ISBT Sci Ser – volume: 114 start-page: 4279 year: 2009 end-page: 4282 article-title: Immunogenicity of blood group antigens: a mathematical model corrected for antibody evanescence with exclusion of naturally occurring and pregnancy related antibodies publication-title: Blood – volume: 49 start-page: 453 year: 2009 end-page: 457 article-title: Alloimmune response after additional red blood cell antigen challenge in immunized haematooncology patients publication-title: Transfusion – volume: 50 start-page: 20 year: 2010 end-page: 25 article-title: Red blood cell alloimmunization in sickle cell disease in Uganda publication-title: Transfusion – volume: 44 start-page: 73 year: 2011 end-page: 79 article-title: The role of molecular immunohematology in sickle cell disease publication-title: Transfus Apher Sci – volume: 45 start-page: 199 year: 2011 end-page: 202 article-title: High frequency of autoimmunization among transfusion‐dependent Tunisian thalassemia patients publication-title: Transfus Apher Sci – volume: 30 start-page: 532 year: 1990 end-page: 535 article-title: Incidence of red cell antibodies after multiple blood transfusions publication-title: Transfusion – volume: 322 start-page: 1617 year: 1990 end-page: 1621 article-title: Alloimmunization in sickle cell anemia and transfusion of racially unmatched blood publication-title: N Engl J Med – volume: 45 start-page: 167 year: 2011 end-page: 170 article-title: Alloimmunization to red cells in thalassemics: emerging problem and future strategies publication-title: Transfus Apher Sci – volume: 52 start-page: 2220 year: 2012 end-page: 2224 article-title: Clinically significant red blood cell antibodies in chronically transfused patients: a survey of Chinese thalassemia major patients and literature review publication-title: Transfusion – volume: 52 start-page: 43 year: 2012 end-page: 47 article-title: Red blood cell alloimmunization in transfusion‐dependent Egyptian patients with thalassemia in a limited donor exposure program publication-title: Transfusion – volume: 76 start-page: 1431 year: 1990 end-page: 1437 article-title: Transfusion and alloimmunization in sickle cell disease. The Cooperative Study of Sickle Cell Disease publication-title: Blood – volume: 24 start-page: 190 year: 2008 end-page: 195 article-title: The potential of blood group genotyping for transfusion medicine practice publication-title: Immunohematology – volume: 7 start-page: 94 year: 2009 end-page: 99 article-title: The Immunohematology Reference Laboratory: the experience of the Policlinico Maggiore Hospital, Mangiagalli and Regina Elena Foundation, Milan publication-title: Blood Transfus – volume: 96 start-page: 3369 year: 2000 end-page: 3373 article-title: Alloimmunization and erythrocyte autoimmunization in transfusion‐dependent thalassemia patients of predominantly Asian descent publication-title: Blood – year: 2012 – volume: 53 start-page: 710 year: 2013 end-page: 715 article-title: Red blood cell alloimmunization in transfused patients with myelodysplastic syndrome or chronic myelomonocytic leukemia publication-title: Transfusion – volume: 5 start-page: 217 year: 2007 end-page: 226 article-title: Strategies for the transfusion of subjects with complex red cell immunization: the Bank of rare blood donors of the Region of Lombardy publication-title: Blood Transfus – volume: 25 start-page: 110 year: 1985 end-page: 112 article-title: Red cell alloantibodies in thalassemia major. Results of an Italian cooperative study publication-title: Transfusion – volume: 7 start-page: 129 year: 2012 end-page: 133 article-title: Red blood alloimmunization and antigen matching in sickle cell disease ‐ the African perspective publication-title: ISBT Sci Ser – volume: 44 start-page: 5 year: 2004 end-page: 9 article-title: Autoantibodies induced by blood transfusion publication-title: Transfusion – volume: 22 start-page: 117 year: 2008 end-page: 132 article-title: Integrating molecular technologies for red blood cell typing and compatibility testing into blood centers and transfusion services publication-title: Transfus Med Rev – volume: 33 start-page: 409 year: 2011 end-page: 414 article-title: Alloimmunization and erythrocyte autoimmunization in transfusion‐dependent Egyptian thalassemic patients publication-title: J Ped Hematol Oncol – volume: 50 start-page: 246 year: 2010 end-page: 256 article-title: Toward extended phenotype matching: a new operational paradigm for the transfusion service publication-title: Transfusion – volume: 120 start-page: 528 year: 2012 end-page: 537 article-title: Red blood cell alloimmunization in sickle cell disease: pathophysiology, risk factors, and transfusion management publication-title: Blood – volume: 49 start-page: 2412 year: 2009 end-page: 2417 article-title: Positive association of DRB1*04 and DRB1*15 alleles with Fy immunization in a Southern European population publication-title: Transfusion – volume: 18 start-page: 527 year: 2011 end-page: 535 article-title: Relevance of RH variants in transfusion of sickle cell patients publication-title: Transfus Clin Biol – volume: 114 start-page: 248 year: 2009 end-page: 256 article-title: Red cell genotyping and the future of pretransfusion testing publication-title: Blood – volume: 17 start-page: 254 year: 2010 end-page: 259 article-title: Multiple transfusions for sickle cell disease in the Democratic of Congo: the importance of the hepatitis C virus publication-title: Transfus Clin Biol – volume: 84 start-page: 462 year: 2009 end-page: 464 article-title: HLA type and risk of alloimmunization in sickle cell disease publication-title: Am J Hematol – volume: 153 start-page: 121 year: 2011 end-page: 128 article-title: Red cell alloimmunization in a diverse population of transfused patients with thalassemia publication-title: Br J Haematol – volume: 112 start-page: 2546 year: 2008 end-page: 2553 article-title: Stochastic modeling of human RBC alloimmunization: evidence for a distinct population of immunologic responders publication-title: Blood – volume: 44 start-page: 81 year: 2011 end-page: 91 article-title: Molecular genetics and clinical applications for RH publication-title: Transfus Apher Sci – volume: 47 start-page: 2189 year: 2007 end-page: 2196 article-title: Transfusion‐induced autoantibodies and differential immunogenicity of blood group antigens: a novel hypothesis publication-title: Transfusion – ident: e_1_2_10_8_1 doi: 10.1111/j.1423-0410.2010.01462.x – ident: e_1_2_10_52_1 doi: 10.1097/MPH.0b013e3182208154 – volume: 37 start-page: 1015 year: 2006 ident: e_1_2_10_58_1 article-title: Red cell immunization in multiply transfused Malay thalassemic patients publication-title: Southest Asian J Trop Med Public Health – ident: e_1_2_10_48_1 doi: 10.1097/MAJ.0b013e3181c70e14 – ident: e_1_2_10_5_1 – ident: e_1_2_10_29_1 doi: 10.1111/j.1537-2995.1961.tb00048.x – ident: e_1_2_10_37_1 doi: 10.1016/j.tracli.2012.03.004 – ident: e_1_2_10_28_1 doi: 10.1182/blood-2009-06-227793 – ident: e_1_2_10_27_1 doi: 10.1111/j.1537-2995.2008.02014.x – ident: e_1_2_10_63_1 doi: 10.1016/j.transci.2011.08.003 – ident: e_1_2_10_65_1 doi: 10.1046/j.1537-2995.1990.30690333485.x – ident: e_1_2_10_36_1 doi: 10.1002/ajh.22167 – ident: e_1_2_10_40_1 doi: 10.1016/j.tracli.2010.09.002 – ident: e_1_2_10_31_1 doi: 10.1111/j.1537-2995.2009.02369.x – ident: e_1_2_10_34_1 doi: 10.1016/j.transci.2010.12.014 – volume: 5 start-page: 217 year: 2007 ident: e_1_2_10_16_1 article-title: Strategies for the transfusion of subjects with complex red cell immunization: the Bank of rare blood donors of the Region of Lombardy publication-title: Blood Transfus – ident: e_1_2_10_50_1 doi: 10.1046/j.1365-2141.1999.01127.x – ident: e_1_2_10_49_1 doi: 10.1111/j.0041-1132.2004.00658.x – ident: e_1_2_10_30_1 doi: 10.1182/blood-2008-03-146415 – ident: e_1_2_10_41_1 doi: 10.1111/j.1537-2995.2009.02435.x – ident: e_1_2_10_54_1 doi: 10.1046/j.1537-2995.1985.25285169198.x – ident: e_1_2_10_51_1 doi: 10.1111/j.1537-2995.2008.01693.x – ident: e_1_2_10_24_1 doi: 10.1111/j.1537-2995.2012.03819.x – volume-title: The Blood Group Antigen Facts Book year: 2012 ident: e_1_2_10_13_1 – ident: e_1_2_10_26_1 doi: 10.1111/j.1537-2995.2006.00764.x – ident: e_1_2_10_11_1 doi: 10.1182/blood-2008-11-146860 – ident: e_1_2_10_7_1 – ident: e_1_2_10_23_1 doi: 10.1111/j.1537-2995.2008.01980.x – ident: e_1_2_10_32_1 doi: 10.1002/ajh.21442 – ident: e_1_2_10_61_1 doi: 10.1111/j.1365-2141.2005.05408.x – ident: e_1_2_10_14_1 doi: 10.1016/j.tmrv.2007.12.002 – ident: e_1_2_10_71_1 doi: 10.1046/j.1537-2995.1994.34794330008.x – ident: e_1_2_10_64_1 doi: 10.1111/j.1537-2995.2007.01468.x – ident: e_1_2_10_17_1 doi: 10.21307/immunohematology-2019-169 – ident: e_1_2_10_15_1 doi: 10.21307/immunohematology-2019-297 – ident: e_1_2_10_47_1 doi: 10.1016/j.transci.2010.12.013 – ident: e_1_2_10_22_1 doi: 10.1111/j.1537-2995.2012.03570.x – ident: e_1_2_10_39_1 doi: 10.1111/j.1537-2995.2010.03045.x – ident: e_1_2_10_72_1 doi: 10.1111/j.1537-2995.2009.02518.x – ident: e_1_2_10_3_1 doi: 10.1111/j.1365-2141.2008.07285.x – volume: 7 start-page: 94 year: 2009 ident: e_1_2_10_21_1 article-title: The Immunohematology Reference Laboratory: the experience of the Policlinico Maggiore Hospital, Mangiagalli and Regina Elena Foundation, Milan publication-title: Blood Transfus – ident: e_1_2_10_56_1 doi: 10.1182/blood.V96.10.3369 – volume-title: Standards for Blood Banks and Transfusion Services year: 2011 ident: e_1_2_10_18_1 – ident: e_1_2_10_53_1 doi: 10.1111/j.1537-2995.2011.03234.x – ident: e_1_2_10_57_1 doi: 10.1046/j.1537-2995.2003.00549.x – ident: e_1_2_10_62_1 doi: 10.1111/j.1365-2141.2011.08576.x – ident: e_1_2_10_59_1 doi: 10.3109/08880018.2011.568595 – ident: e_1_2_10_46_1 – ident: e_1_2_10_2_1 doi: 10.1182/blood-2011-11-327361 – ident: e_1_2_10_35_1 doi: 10.1111/j.1751-2824.2012.01572.x – volume: 50 start-page: 246 year: 2010 ident: e_1_2_10_68_1 article-title: Toward extended phenotype matching: a new operational paradigm for the transfusion service publication-title: Transfusion doi: 10.1111/j.1537-2995.2009.02462.x – ident: e_1_2_10_42_1 doi: 10.1046/j.1365-2141.2001.02819.x – ident: e_1_2_10_45_1 doi: 10.1111/j.1537-2995.2012.03796.x – ident: e_1_2_10_9_1 doi: 10.1111/j.1537-2995.2009.02456.x – ident: e_1_2_10_44_1 doi: 10.1056/NEJM199006073222301 – ident: e_1_2_10_38_1 doi: 10.1111/j.1537-2995.2011.03502.x – ident: e_1_2_10_43_1 doi: 10.1111/j.1537-2995.2009.02185.x – ident: e_1_2_10_60_1 doi: 10.1016/j.transci.2011.07.014 – ident: e_1_2_10_25_1 doi: 10.1111/j.1537-2995.2007.01433.x – ident: e_1_2_10_19_1 doi: 10.1111/j.1751-2824.2012.01594.x – ident: e_1_2_10_66_1 doi: 10.1111/j.1423-0410.2011.01517.x – ident: e_1_2_10_69_1 doi: 10.1182/blood.V76.7.1431.1431 – ident: e_1_2_10_4_1 doi: 10.1111/bjh.12061 – ident: e_1_2_10_6_1 – ident: e_1_2_10_20_1 doi: 10.1111/j.1751-2824.2012.01574.x – ident: e_1_2_10_55_1 doi: 10.1111/j.1423-0410.1990.tb02055.x – ident: e_1_2_10_70_1 doi: 10.1046/j.1537-2995.2002.00126.x – ident: e_1_2_10_10_1 doi: 10.1159/000212062 – ident: e_1_2_10_33_1 doi: 10.1016/j.tracli.2011.09.001 – ident: e_1_2_10_67_1 doi: 10.1111/j.1423-0410.2009.01185.x – volume: 28 start-page: 20 year: 2012 ident: e_1_2_10_12_1 article-title: The prevention and management of alloimmunization in sickle cell disease: The benefit of extended phenotypic matching of red blood cells publication-title: Immunohematology doi: 10.21307/immunohematology-2019-144 |
| SSID | ssj0008285 |
| Score | 2.33575 |
| SecondaryResourceType | review_article |
| Snippet | Red blood cell (RBC) transfusions are a milestone in the treatment for sickle cell anaemia (SSA) and for thalassaemia. RBC alloimmunization remains a major... Red blood cell ( RBC ) transfusions are a milestone in the treatment for sickle cell anaemia ( SSA ) and for thalassaemia. RBC alloimmunization remains a major... |
| SourceID | unpaywall proquest pubmed crossref wiley istex |
| SourceType | Open Access Repository Aggregation Database Index Database Enrichment Source Publisher |
| StartPage | 197 |
| SubjectTerms | Anemia, Sickle Cell - blood Anemia, Sickle Cell - immunology Anemia, Sickle Cell - therapy Antigens Blood Group Incompatibility - blood Blood Group Incompatibility - complications Blood Group Incompatibility - immunology Blood Grouping and Crossmatching - methods Blood Grouping and Crossmatching - standards Blood Grouping and Crossmatching - trends blood groups Blood Transfusion - standards Blood Transfusion - trends Blood transfusions Erythrocytes Forecasting genotyping Humans Immunization, Passive - trends immunohaematology Isoantibodies - biosynthesis Isoantibodies - blood Molecular biology RBC antigens and antibodies Risk Factors Sickle cell disease Thalassemia - blood Thalassemia - immunology Thalassemia - therapy Transfusion Reaction transfusion strategy |
| SummonAdditionalLinks | – databaseName: Unpaywall dbid: UNPAY link: http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwpV1Lb9QwEB7BrgTlwLsQKMg8hHogS16OE24V0K4QXSrUheUUHNsRq90mUTeBlh_C78UTJ0GLSoXELZLHUWzPTD7b880APPVYJjwhpZ3JKLADz_XtVHs9W7pMiTCiIhZ43rE_CcfT4O2Mzto6p8iFMfkh-gM3tIzGX6OBlzIzfr4z9RffipOR62lUfhGGId4wDWA4nRzsfO6IJ7HTEKZdDRpsJ3CdNrfQWt-1P9IQJ_fkLLh5BS7XeclPv_Plch3JNr-i3WvwpRuEiUBZjOoqHYkff-R3_I9RXoerLUwlO0avbsAFld-ES_vtRfwt-PlBSdIEvRM8-id4fT9vqCaG1knmOdHrv1gq097eAxGeS2yqviJ9c8XV0Zy_JMLkiCJIbqpXz4nJc0LK3zzQVdOxLCqMbdLfhTGRpMjIUVfcl1SnSPy6DdPdN4evxnZb4sEWAY1Dm4pI6k2nk2UqpEw6mchYQIMwlExopMYVV45SQSalH0eCMSpSLrWPjqTIaBopfxMGeZGru0B4pDQYSanwQollMVNfxQzxiqSuSn1mwXa3zIlo859jGY5l0u2D9DwnzTxb8LgXLU3Sj7OEnjW60kvw4wVGyTGafJrsJQfRu_Ge-zpMDi3Y6pQpaR3EKsE0_LGLeQgseNQ3a9PGReG5KmqU0f4SKwOxc2VCPWNayII7RlH7D9LgzNWbJ9-CJ73mnjee7UYR_y6RfHw_ax7u_dML78OGRpdtmNMWDKrjWj3QCK5KH7ZW-gvbakb5 priority: 102 providerName: Unpaywall |
| Title | Red blood cell alloimmunization in sickle cell disease and in thalassaemia: current status, future perspectives and potential role of molecular typing |
| URI | https://api.istex.fr/ark:/67375/WNG-P8LHG1D6-T/fulltext.pdf https://onlinelibrary.wiley.com/doi/abs/10.1111%2Fvox.12086 https://www.ncbi.nlm.nih.gov/pubmed/24117723 https://www.proquest.com/docview/1508914316 https://www.proquest.com/docview/1510111707 https://www.proquest.com/docview/1516745170 https://onlinelibrary.wiley.com/doi/pdfdirect/10.1111/vox.12086 |
| UnpaywallVersion | publishedVersion |
| Volume | 106 |
| hasFullText | 1 |
| inHoldings | 1 |
| isFullTextHit | |
| isPrint | |
| journalDatabaseRights | – providerCode: PRVEBS databaseName: EBSCOhost Academic Search Ultimate customDbUrl: https://search.ebscohost.com/login.aspx?authtype=ip,shib&custid=s3936755&profile=ehost&defaultdb=asn eissn: 1423-0410 dateEnd: 20241002 omitProxy: true ssIdentifier: ssj0008285 issn: 0042-9007 databaseCode: ABDBF dateStart: 20010101 isFulltext: true titleUrlDefault: https://search.ebscohost.com/direct.asp?db=asn providerName: EBSCOhost – providerCode: PRVWIB databaseName: Wiley Online Library - Core collection (SURFmarket) issn: 0042-9007 databaseCode: DR2 dateStart: 19970101 customDbUrl: isFulltext: true eissn: 1423-0410 dateEnd: 99991231 omitProxy: false ssIdentifier: ssj0008285 providerName: Wiley-Blackwell |
| link | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnV1Zb9QwEB5VrcTxwH0ESmUOoT6Q1eZwnMBTBbQrRJeq6sIiIVmO7YjVbpNVk0DLD-H34nGOUlQqxFskjyXHnhl_tme-AXjms0z6Uik3U3Hohr4XuKnxeq7ymJZRTGUi8b5jdxyNJuG7KZ2uwKsuF6bhh-gv3NAyrL9GAxdp-ZuRfyuOB55vELnxv15A7RPt_il1FDKzdeknidkIW1YhjOLpe57Zi9ZwWo_PA5pX4XKdL8XJd7FYnMWwdhPavg5fuuE3sSfzQV2lA_njD2bH__y_G3CtBadkq9Gmm7Ci81twabd9fr8NP_e1IjbUneCFP8FH-5lNMGmSOcksJ2bV5wvdtLevP0TkCpuqr5i0WQp9OBMviWyYoQimNNXlC9Kwm5DlafZnaTsuiwojmsy4MBKSFBk57Er6kuoE073uwGT77cHrkdsWdnBlSJPIpTJW5qg5zDIdUaaGmcxYSMMoUkwafCa00EOtw0ypIIklY1SmQhnPHCuZ0TTWwV1YzYtc3wciYm0gSEqlHykshpkGOmGIUhT1dBowBza7JeayZT3H4hsL3p1-zDxzO88OPOlFlw3Vx3lCz62e9BLiaI6xcYzyT-Mdvhe_H-14byJ-4MB6p0i8dQslR_L9xEP2AQce983GoHFRRK6LGmWMl8R6QOxCmcjMmBFy4F6jpP2ADCTzzJEpcOBpr7UX_c-mVcK_S_CPH6b248G_iz6EKwZYthFO67BaHdX6kQFvVbphrXQD1ibjva3PvwCk2ERr |
| linkProvider | Wiley-Blackwell |
| linkToHtml | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnV3db9MwED-NTWLwwPdHYID50LQHUjVNHCeIF8TYCrQFTR30BVmO7YiqXVKtCWz8Ify9-JyPMTQmxFskn6XYvjv_bN_9DuBZj6WyJ5VyUxUFbtDzfDcxXs9VHtMyjKiMJd53DEdhfz94N6GTFXjZ5MJU_BDthRtahvXXaOB4If2blX_Ljzpez0DyC7CG73Noltt7J-RRyM3WJKDEZiuseYUwjqftemo3WsOJPToLal6G9TJbiOPvYj4_jWLtNrRzFb40A6iiT2adskg68scf3I7_O8JrcKXGp-RVpVDXYUVnN-DisH6Bvwk_97QiNtqd4J0_wXf7qc0xqfI5yTQjZuFnc1211w9ARGQKm4qvmLe5FPpgKl4QWZFDEcxqKpfPSUVwQhYnCaBL23GRFxjUZP4LgyFJnpKDpqovKY4x4-sW7O-8Gb_uu3VtB1cGNA5dKiNlTpvdNNUhZaqbypQFNAhDxaSBaEIL3dU6SJXy40gyRmUilHHOkZIpTSLt34bVLM_0XSAi0gaFJFT2QoX1MBNfxwyBiqKeTnzmwFazxlzWxOdYf2POmwOQmWdu59mBJ63oomL7OEto0ypKKyEOZxgexyj_PNrlH6NBf9fbDvnYgY1Gk3jtGZYc-fdjDwkIHHjcNhubxkURmc5LlDGOEksCsXNlQjNjRsiBO5WWtj9kUJlnTk2-A09btT1vPFtWC_8uwT99mNiPe_8u-gjW--PhgA_ejt7fh0sGZ9YBTxuwWhyW-oHBckXy0JrsL4Q8Rtc |
| linkToPdf | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnV1Zb9QwEB6VVirwwH0ECphDqA9ktTlsJ_CEKNsF2qWqWtgHpMjxIVa7zUbdBFp-CL8XT65SVCrEWySPJceeGX-2Z74BeOZzI32plGtUFLqh7wVuar2eqzyuJYuojCXed2yP2HA_fD-m4yV41ebC1PwQ3YUbWkblr9HAc2V-M_Jv86Oe51tEfgFWQmZPV4iIdk-4o5Carc0_ie1O2NAKYRhP1_XUZrSC83p0FtK8DBfLLBfH38VsdhrEVrvQ4Cp8acdfB59Me2WR9uSPP6gd__MHr8GVBp2S17U6XYclnd2A1e3m_f0m_NzVilSx7gRv_Am-2k-qDJM6m5NMMmKXfTrTdXvz_ENEprCp-IpZmwuhDybiJZE1NRTBnKZy8YLU9CYkP0n_XFQd83mBIU12XBgKSeaGHLQ1fUlxjPlet2B_8HbvzdBtKju4MqQxc6mMlD1r9o3RjHLVN9LwkIaMKS4tQBNa6L7WoVEqiCPJOZWpUNY1R0oamkY6uA3L2TzTd4GISFsMklLpM4XVMNNAxxxhiqKeTgPuwHq7xIlsaM-x-sYsaY8_dp6Tap4deNKJ5jXXx1lCzys96STE4RSD4zhNPo82k51oa7jpbbBkz4G1VpGSxi8sEmTfjz2kH3DgcddsLRoXRWR6XqKMdZNYEIifK8PsjFkhB-7UStoNyGIyz56ZAgeedlp73v-sV0r4d4nk08dx9XHv30UfwerOxiDZejf6cB8uWZDZRDutwXJxWOoHFsgV6cPKYH8BgrFFhg |
| linkToUnpaywall | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwpV1Lb9QwEB7BrgTlwLsQKMg8hHogS16OE24V0K4QXSrUheUUHNsRq90mUTeBlh_C78UTJ0GLSoXELZLHUWzPTD7b880APPVYJjwhpZ3JKLADz_XtVHs9W7pMiTCiIhZ43rE_CcfT4O2Mzto6p8iFMfkh-gM3tIzGX6OBlzIzfr4z9RffipOR62lUfhGGId4wDWA4nRzsfO6IJ7HTEKZdDRpsJ3CdNrfQWt-1P9IQJ_fkLLh5BS7XeclPv_Plch3JNr-i3WvwpRuEiUBZjOoqHYkff-R3_I9RXoerLUwlO0avbsAFld-ES_vtRfwt-PlBSdIEvRM8-id4fT9vqCaG1knmOdHrv1gq097eAxGeS2yqviJ9c8XV0Zy_JMLkiCJIbqpXz4nJc0LK3zzQVdOxLCqMbdLfhTGRpMjIUVfcl1SnSPy6DdPdN4evxnZb4sEWAY1Dm4pI6k2nk2UqpEw6mchYQIMwlExopMYVV45SQSalH0eCMSpSLrWPjqTIaBopfxMGeZGru0B4pDQYSanwQollMVNfxQzxiqSuSn1mwXa3zIlo859jGY5l0u2D9DwnzTxb8LgXLU3Sj7OEnjW60kvw4wVGyTGafJrsJQfRu_Ge-zpMDi3Y6pQpaR3EKsE0_LGLeQgseNQ3a9PGReG5KmqU0f4SKwOxc2VCPWNayII7RlH7D9LgzNWbJ9-CJ73mnjee7UYR_y6RfHw_ax7u_dML78OGRpdtmNMWDKrjWj3QCK5KH7ZW-gvbakb5 |
| openUrl | ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Red+blood+cell+alloimmunization+in+sickle+cell+disease+and+in+thalassaemia%3A+current+status%2C+future+perspectives+and+potential+role+of+molecular+typing&rft.jtitle=Vox+sanguinis&rft.au=Matteocci%2C+A.&rft.au=Pierelli%2C+L.&rft.date=2014-04-01&rft.pub=Blackwell+Publishing+Ltd&rft.issn=0042-9007&rft.eissn=1423-0410&rft.volume=106&rft.issue=3&rft.spage=197&rft.epage=208&rft_id=info:doi/10.1111%2Fvox.12086&rft.externalDBID=n%2Fa&rft.externalDocID=ark_67375_WNG_P8LHG1D6_T |
| thumbnail_l | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=0042-9007&client=summon |
| thumbnail_m | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=0042-9007&client=summon |
| thumbnail_s | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=0042-9007&client=summon |